By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Adamis Pharmaceuticals 

2658 Del Mar Heights Road
Suite 555
Del Mar  California  92014   U.S.A.
Phone: n/a Fax: n/a




Company News
Adamis (ADMP) Strengthens Patent Portfolio For Its Dry Powder Inhaler 8/3/2016 7:54:05 AM
Adamis (ADMP) Announces $11.1 Million Registered Direct Offering 7/29/2016 8:16:40 AM
Allergan (AGN)'s Watson Laboratories (WPI) Opts to Terminate Epinephrine PFS Agreement With Adamis (ADMP) 7/21/2016 7:20:59 AM
Adamis (ADMP) Announces Private Placement 7/12/2016 8:15:19 AM
Adamis (ADMP) Stock Tanks After the FDA Rejects Emergency Drug for Severe Allergic Reaction 6/6/2016 6:26:51 AM
Adamis (ADMP) Announces FDA Acceptance Of Resubmission Of Its Epinephrine Pre-Filled Syringe NDA 1/15/2016 7:53:34 AM
Adamis (ADMP) Announces NDA Resubmission Of Its Epinephrine Pre-Filled Syringe Application To The FDA 12/7/2015 7:55:27 AM
Adamis (ADMP) Pharmaceuticals Announces Positive Clinical Study Results For Its Albuterol (Salbutamol) HFA Product 4/16/2015 7:18:32 AM
Adamis (ADMP) Announces Key Additions To Its Commercial Sales Team 4/15/2015 7:18:29 AM
Adamis (ADMP) Plummets More Than 30% After FDA Rejects Its Allergy Shot Application 3/30/2015 8:34:14 AM